한글목차

세포 분리 세계 시장은 2024년에 34억 7,000만 달러로 평가되었으며, 2030년에는 47억 6,000만 달러에 달하고, CAGR 5.62%로 확대될 것으로 예측됩니다.

세포분리(혼합된 집단에서 특정 세포 유형을 분리하는 과정)는 재생의학, 암 연구, 면역치료, 줄기세포 생물학 등의 분야에서 기초가 되고 있습니다. 생명과학 분야의 발전에 따라 고순도, 생존 가능한 세포에 대한 수요가 증가하면서 세포 분리의 정확성, 확장성, 효율성을 높이는 기술에 대한 투자가 증가하고 있습니다.

성장의 주요 원동력은 맞춤형 의료의 채택이 확대되고 있다는 점입니다. 맞춤의료는 표적 치료제 개발을 위해 환자 고유의 세포를 분리하는 것에 의존하고 있습니다. 이러한 요구는 면역요법이나 세포 기반 치료가 정확한 세포 선택이 필요한 종양학에서 특히 두드러집니다. 높은 비용과 기술적 장벽, 특히 희귀하고 민감한 세포를 분리하는 데 있어 높은 비용과 기술적 장벽이 문제이지만, 아시아태평양의 신흥 시장은 의료 인프라, 연구 역량, 의약품 제조에 대한 투자 확대에 힘입어 새로운 성장 기회를 창출하고 있습니다.

주요 시장 촉진요인

헬스케어 산업의 성장

주요 시장 과제

세포 분리 기술의 높은 비용

주요 시장 동향

세포 기반 치료에 대한 수요 증가

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 COVID-19가 세계의 세포 분리 시장에 미치는 영향

제5장 세계의 세포 분리 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 세포 종류별(인간 세포, 동물 세포)
  • 용도별(생체분자 분리, 암 조사, 줄기세포 조사, 체외진단, 기타)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 세포 분리 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제7장 유럽의 세포 분리 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 세포 분리 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 한국
  • 일본
  • 호주

제9장 남미의 세포 분리 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 세포 분리 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 혼란 : 분쟁, 팬데믹, 무역장벽

제14장 세계의 세포 분리 시장 : SWOT 분석

제15장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제16장 경쟁 구도

• Becton, Dickinson & Company
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc.
• Terumo Corporation
• PluriSelect Life Science UG & Co. KG
• Danaher Corporation
• STEMCELL Technologies Inc.
• Corning Inc.
• Akadeum Life Sciences Inc.

제17장 전략적 제안

제18장 조사 회사 소개 및 면책사항

영문목차

The Global Cell Isolation Market was valued at USD 3.47 billion in 2024 and is projected to reach USD 4.76 billion by 2030, expanding at a CAGR of 5.62%. Cell isolation-the process of separating specific cell types from a mixed population-is fundamental in fields such as regenerative medicine, cancer research, immunotherapy, and stem cell biology. As the life sciences sector advances, the demand for high-purity and viable cells is driving increased investment in technologies that offer enhanced precision, scalability, and efficiency in cell separation.

A primary growth driver is the growing adoption of personalized medicine, which depends on isolating patient-specific cells for the development of targeted therapies. This need is particularly prominent in oncology, where immunotherapies and cell-based treatments require accurate cell selection. While high costs and technical barriers pose challenges-especially in isolating rare or delicate cell types-emerging markets in the Asia-Pacific region are creating new opportunities for expansion, supported by growing investments in healthcare infrastructure, research capabilities, and pharmaceutical manufacturing.

Key Market Drivers

Growth in Healthcare Industry

The expansion of the global healthcare industry is a central factor driving the growth of the cell isolation market. With annual revenues exceeding USD 4 trillion, healthcare is supported by key sectors such as pharmaceuticals and biotechnology, contributing nearly USD 850 billion, and medical technology and diagnostics, which account for over USD 400 billion. This industry growth-especially in emerging economies-is accelerating the adoption of advanced diagnostic and therapeutic tools, including cell-based solutions.

As hospitals, laboratories, and pharmaceutical firms increasingly invest in regenerative therapies and precision medicine, the demand for scalable and reliable cell isolation techniques is rising. Additionally, the increasing global prevalence of chronic illnesses, including cancer and autoimmune diseases, has intensified the need for targeted therapies. In 2021, noncommunicable diseases were responsible for over 43 million deaths globally, with the majority occurring prematurely in low- and middle-income countries-reinforcing the importance of cell-based technologies for future treatment protocols.

Key Market Challenges

High Cost of Cell Isolation Technologies

The high cost associated with cell isolation technologies continues to be a major limitation for broader adoption, particularly in resource-limited settings. Systems like fluorescence-activated cell sorting (FACS) and magnetic-activated cell sorting (MACS) require sophisticated instruments, proprietary reagents, and specialized personnel, all contributing to significant operational costs.

These expenses present a substantial barrier for smaller laboratories, academic institutions, and biotech startups. Moreover, ongoing costs-such as maintenance, consumables, and technical support-can hinder the full utilization of cell isolation tools, especially in developing countries where funding and access to infrastructure are limited.

Key Market Trends

Increased Demand for Cell-Based Therapies

A key trend influencing the cell isolation market is the rising demand for cell-based therapies. By 2035, treatments such as CAR-T, TCR, and TIL therapies are expected to make up over 45% of clinical demand for cell therapy products. These therapies are gaining traction for their ability to address a wide array of diseases, including cancer, autoimmune conditions, and degenerative disorders.

This shift toward cell-based interventions is driving the need for robust isolation technologies that can reliably deliver high-quality, contamination-free, and functional cells. As the industry focuses more on precision medicine, the development and clinical use of cell therapies require advanced systems capable of delivering consistent and reproducible results in complex workflows.

Key Market Players

• Becton, Dickinson & Company
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc.
• Terumo Corporation
• PluriSelect Life Science UG & Co. KG
• Danaher Corporation
• STEMCELL Technologies Inc.
• Corning Inc.
• Akadeum Life Sciences Inc.

Report Scope

In this report, the Global Cell Isolation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Isolation Market, By Cell Type:

• Human Cells
• Animal Cells

Cell Isolation Market, By Application:

• Biomolecule Isolation
• Cancer Research
• Stem Cell Research
• In Vitro Diagnostics
• Others

Cell Isolation Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Isolation Market.

Available Customizations

Global Cell Isolation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Cell Isolation Market

5. Global Cell Isolation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Cell Type (Human Cells, Animal Cells)
  • 5.2.2. By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, In Vitro Diagnostics, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Cell Isolation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Cell Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cell Isolation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Cell Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Mexico Cell Isolation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Cell Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Canada Cell Isolation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Cell Type
      • 6.3.3.2.2. By Application

7. Europe Cell Isolation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Cell Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Cell Isolation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Cell Type
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Cell Isolation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Cell Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Cell Isolation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Cell Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Cell Isolation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Cell Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Cell Isolation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Cell Type
      • 7.3.5.2.2. By Application

8. Asia Pacific Cell Isolation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Cell Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Cell Isolation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Cell Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Cell Isolation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Cell Type
      • 8.3.2.2.2. By Application
  • 8.3.3. South Korea Cell Isolation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Cell Type
      • 8.3.3.2.2. By Application
  • 8.3.4. Japan Cell Isolation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Cell Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Cell Isolation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Cell Type
      • 8.3.5.2.2. By Application

9. South America Cell Isolation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Cell Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cell Isolation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Cell Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Cell Isolation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Cell Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Cell Isolation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Cell Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Cell Isolation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Cell Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cell Isolation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Cell Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Cell Isolation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Cell Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Cell Isolation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Cell Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Cell Isolation Market: SWOT Analysis

15. Porters Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Products

16. Competitive Landscape

• 16.1. Becton, Dickinson & Company
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (As Reported)
  • 16.1.5. Recent Developments
  • 16.1.6. Key Personnel Details
  • 16.1.7. SWOT Analysis
• 16.2. Merck KGaA
• 16.3. Thermo Fisher Scientific Inc.
• 16.4. Bio-Rad Laboratories Inc.
• 16.5. Terumo Corporation
• 16.6. PluriSelect Life Science UG & Co. KG
• 16.7. Danaher Corporation
• 16.8. STEMCELL Technologies Inc.
• 16.9. Corning Inc.
• 16.10. Akadeum Life Sciences Inc.

17. Strategic Recommendations

18. About Us & Disclaimer